Atlas Trials

Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

Clinical trial NCT06480201 · RECRUITING

Trial details

NCT number
NCT06480201
Sponsor
Texas A&M University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
HealthyMajor Depressive DisorderTreatment Resistant Depression
Start date
2024-01-01
Primary completion
2026-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.